1
|
Khizar N, Abbas N, Ahmed M, Ahmad M, Mustafa Z, Jehangir M, Mohammed Al-Ahmary K, Hussain A, Bukhari NI, Ali I. Amelioration of tableting properties and dissolution rate of naproxen co-grinded with nicotinamide: preparation and characterization of co-grinded mixture. Drug Dev Ind Pharm 2024; 50:537-549. [PMID: 38771120 DOI: 10.1080/03639045.2024.2358356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2023] [Accepted: 05/17/2024] [Indexed: 05/22/2024]
Abstract
OBJECTIVE AND SIGNIFICANCE Reducing the dimensions, when other additives are present, shows potential as a method to improve the dissolution and solubility of biopharmaceutical classification system class II drugs that have poor solubility. In this investigation, the process involved grinding naproxen with nicotinamide with the aim of improving solubility and the rate of dissolution. METHODS Naproxen was subjected to co-milling with urea, dimethylurea, and nicotinamide using a planetary ball mill for a duration of 90 min, maintaining a 1:1 molar ratio for the excipients (screening studies). The co-milled combinations, naproxen in its pure milled form, and a physical mixture were subjected to analysis using X-ray powder diffraction (XRPD), scanning electron microscopy (SEM), and solubility assessment. The mixture displaying the highest solubility (naproxen-nicotinamide) was chosen for further investigation, involving testing for intrinsic dissolution rate (IDR) and Fourier-transform infrared spectroscopy (FTIR) after co-milling for both 90 and 480 min. RESULTS AND CONCLUSION The co-milled combination, denoted as S-3b and consisting of the most substantial ratio of nicotinamide to naproxen at 1:3, subjected to 480 min of milling, exhibited a remarkable 45-fold increase in solubility and a 9-fold increase in IDR. XRPD analysis of the co-milled samples demonstrated no amorphization, while SEM images portrayed the aggregates of naproxen with nicotinamide. FTIR outcomes negate the presence of any chemical interactions between the components. The co-milled sample exhibiting the highest solubility and IDR was used to create a tablet, which was then subjected to comprehensive evaluation for standard attributes. The results revealed improved compressibility and dissolution properties.
Collapse
Affiliation(s)
- Nosheen Khizar
- University College of Pharmacy, University of the Punjab, Lahore, Pakistan
| | - Nasir Abbas
- University College of Pharmacy, University of the Punjab, Lahore, Pakistan
| | - Mahmood Ahmed
- Department of Chemistry, Division of Science and Technology, University of Education, Lahore, Pakistan
| | - Muhammad Ahmad
- Department of Chemistry, Division of Science and Technology, University of Education, Lahore, Pakistan
| | - Zeeshan Mustafa
- Department of Physics, Lahore Garrison University, Lahore, Pakistan
| | - Muhammad Jehangir
- Department of Chemistry, FC College (A Chartered University), Lahore, Pakistan
| | | | - Amjad Hussain
- University College of Pharmacy, University of the Punjab, Lahore, Pakistan
| | | | - Ijaz Ali
- Centre for Applied Mathematics and Bioinformatics (CAMB), Gulf University for Science and Technology, Hawally, Kuwait
| |
Collapse
|
2
|
Liu F, Bagi SD, Su Q, Chakrabarti R, Barral R, Gamekkanda JC, Hu C, Mascia S. Targeting Particle Size Specification in Pharmaceutical Crystallization: A Review on Recent Process Design and Development Strategies and Particle Size Measurements. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.2c00277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Affiliation(s)
- Fan Liu
- Jiangsu Key Laboratory of Neuropsychiatric Diseases, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts01801, United States
| | - Sujay D. Bagi
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts01801, United States
| | - Qinglin Su
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts01801, United States
| | - Rajshree Chakrabarti
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts01801, United States
| | - Rita Barral
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts01801, United States
| | - Janaka C. Gamekkanda
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts01801, United States
| | - Chuntian Hu
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts01801, United States
| | - Salvatore Mascia
- CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts01801, United States
| |
Collapse
|
3
|
Abe Y, Emori K. Application of a Statistical Approach to Process Development of Futibatinib by Employing Quality-by-Design Principles. Part 3: Development of Design Space for Control of Particle Size Distribution. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.1c00147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Yasunori Abe
- Chemical Technology Laboratory, CMC Division, Taiho Pharmaceutical Co., Ltd., 200-22 Motohara, Kamikawa-machi, Kodama-gun, Saitama 367-0241, Japan
| | - Kosuke Emori
- Chemical Technology Laboratory, CMC Division, Taiho Pharmaceutical Co., Ltd., 200-22 Motohara, Kamikawa-machi, Kodama-gun, Saitama 367-0241, Japan
| |
Collapse
|
4
|
Binel P, Mazzotti M. Selective Dissolution Process Featuring a Classification Device for the Removal of Fines in Crystallization: Experiments. Ind Eng Chem Res 2021. [DOI: 10.1021/acs.iecr.1c03401] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Pietro Binel
- Institute of Energy and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland
| | - Marco Mazzotti
- Institute of Energy and Process Engineering, ETH Zurich, 8092 Zurich, Switzerland
| |
Collapse
|
5
|
Yang Y, Ahmed B, Mitchell C, Quon JL, Siddique H, Houson I, Florence AJ, Papageorgiou CD. Investigation of Wet Milling and Indirect Ultrasound as Means for Controlling Nucleation in the Continuous Crystallization of an Active Pharmaceutical Ingredient. Org Process Res Dev 2021. [DOI: 10.1021/acs.oprd.1c00209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Yihui Yang
- Process Chemistry and Development, Takeda Pharmaceuticals International Company, Boston, 40 Landsdowne, Cambridge, Massachusetts 02139, United States
| | - Bilal Ahmed
- EPSRC Future CMAC Manufacturing Research Hub, Institute of Pharmacy & Biomedical Sciences, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, U.K
- EPSRC Future CMAC Manufacturing Research Hub, Department of Chemical and Biological Engineering, University of Sheffield, Sheffield S1 3JD, U.K
| | - Christopher Mitchell
- Process Chemistry and Development, Takeda Pharmaceuticals International Company, Boston, 40 Landsdowne, Cambridge, Massachusetts 02139, United States
| | - Justin L. Quon
- Process Chemistry and Development, Takeda Pharmaceuticals International Company, Boston, 40 Landsdowne, Cambridge, Massachusetts 02139, United States
| | - Humera Siddique
- EPSRC Future CMAC Manufacturing Research Hub, Institute of Pharmacy & Biomedical Sciences, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, U.K
| | - Ian Houson
- EPSRC Future CMAC Manufacturing Research Hub, Institute of Pharmacy & Biomedical Sciences, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, U.K
| | - Alastair J. Florence
- EPSRC Future CMAC Manufacturing Research Hub, Institute of Pharmacy & Biomedical Sciences, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, U.K
| | - Charles D. Papageorgiou
- Process Chemistry and Development, Takeda Pharmaceuticals International Company, Boston, 40 Landsdowne, Cambridge, Massachusetts 02139, United States
| |
Collapse
|
6
|
McDonald MA, Salami H, Harris PR, Lagerman CE, Yang X, Bommarius AS, Grover MA, Rousseau RW. Reactive crystallization: a review. REACT CHEM ENG 2021. [DOI: 10.1039/d0re00272k] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Reactive crystallization is not new, but there has been recent growth in its use as a means of improving performance and sustainability of industrial processes.
Collapse
Affiliation(s)
- Matthew A. McDonald
- School of Chemical and Biomolecular Engineering
- Georgia Institute of Technology
- Atlanta
- USA
| | - Hossein Salami
- School of Chemical and Biomolecular Engineering
- Georgia Institute of Technology
- Atlanta
- USA
| | - Patrick R. Harris
- School of Chemical and Biomolecular Engineering
- Georgia Institute of Technology
- Atlanta
- USA
| | - Colton E. Lagerman
- School of Chemical and Biomolecular Engineering
- Georgia Institute of Technology
- Atlanta
- USA
| | - Xiaochuan Yang
- Office of Pharmaceutical Quality
- Center for Drug Evaluation and Research
- U.S. Food and Drug Administration
- Silver Spring
- USA
| | - Andreas S. Bommarius
- School of Chemical and Biomolecular Engineering
- Georgia Institute of Technology
- Atlanta
- USA
| | - Martha A. Grover
- School of Chemical and Biomolecular Engineering
- Georgia Institute of Technology
- Atlanta
- USA
| | - Ronald W. Rousseau
- School of Chemical and Biomolecular Engineering
- Georgia Institute of Technology
- Atlanta
- USA
| |
Collapse
|